This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a ceiling value of $2,104 and a completion date of September 9, 2024. It is a firm-fixed price delivery order contract, meaning AmerisourceBergen will provide the medication at a pre-determined price. This contract is likely part of a larger indefinite delivery contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued up to $999,999,999, to deliver a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation, indicating it was competitively awarded.
Generated 12/6/24, 9:03 AM